Valuation : Medpace Holdings, Inc.

Market Cap 16.58B 14.3B 13.45B 12.26B 23.05B 1,573B 23.17B 159B 61.9B 800B 62.25B 60.9B 2,654B P/E 2026 *
33.8x
P/E 2027 * 31x
Enterprise Value 15.78B 13.61B 12.8B 11.66B 21.93B 1,497B 22.05B 151B 58.9B 762B 59.23B 57.95B 2,526B EV / Sales 2026 *
5.53x
EV / Sales 2027 * 5.06x
Free-Float
80.32%
Yield 2026 *
-
Yield 2027 * -
1 day-1.25%
1 week-4.74%
Current month-1.52%
1 month+2.03%
3 months+29.57%
6 months+27.87%
Current year+4.15%
1 week 583.16
Extreme 583.1575
624.99
1 month 563.45
Extreme 563.45
629.69
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/26 Exercice

Director

11,574 0.0415%
26/08/26 Sell

Chief Executive Officer

-4,000 0.0143%
24/08/26 Sell

Chief Executive Officer

-1,983 0.0071%
Change 5-day change 1-year change 3-year change Capi.($)
-1.26%-4.74%+23.58%+113.88% 16.58B
+0.21%-2.69%+1.19%+17.32% 49.81B
+1.26%-1.34%+427.55%+494.98% 44.06B
-0.62%-0.32%+40.74%+15.28% 42.99B
-0.48%-4.95%+7.74%+71.23% 40.88B
-0.48%-3.09%+17.78%+49.80% 33.11B
-1.33%+2.39% - - 17.27B
-1.35%-3.40%+10.13%+26.34% 14.63B
-1.74%-5.01%+75.34%+34.88% 13.76B
-1.95%-4.66%-9.45%-38.70% 12.73B
Average -0.76%-1.96%+66.07%+87.22% 28.58B
Weighted average by Cap. -0.34%-1.93%+85.68%+112.27%

Financials

2026 *2027 *
Net sales 2.85B 2.46B 2.31B 2.11B 3.96B 271B 3.99B 27.36B 10.65B 138B 10.71B 10.47B 457B 3.03B 2.61B 2.46B 2.24B 4.21B 287B 4.23B 29.04B 11.3B 146B 11.36B 11.12B 485B
Net income 503M 434M 408M 371M 699M 47.7B 702M 4.82B 1.88B 24.26B 1.89B 1.85B 80.45B 547M 471M 444M 404M 760M 51.87B 764M 5.24B 2.04B 26.39B 2.05B 2.01B 87.5B
Net Debt -802M -692M -651M -593M -1.12B -76.14B -1.12B -7.7B -3B -38.73B -3.01B -2.95B -128B -1.25B -1.08B -1.02B -926M -1.74B -119B -1.75B -12.01B -4.68B -60.45B -4.7B -4.6B -200B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
01/09/26 $585.62 -1.41% 74,383
31/08/26 $593.99 -1.11% 347,286
28/08/26 $600.65 -1.79% 186,917
27/08/26 $611.57 -1.21% 198,155
26/08/26 $619.05 +0.81% 149,419
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
593.99USD
Average target price
581.83USD
Spread / Average Target
-2.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock